Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
Takashi Nagahara, Tsuyoshi Saitoh, Noriki Kutsumura, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 20, pp. 7931-7937
Closed Access | Times Cited: 109

Showing 51-75 of 109 citing articles:

Azulene-based compounds for targeting orexin receptors
Teppo O. Leino, Ainoleena Turku, Jari Yli‐Kauhaluoma, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 88-100
Closed Access | Times Cited: 21
Discovery of the First Selective, Nonpeptidic Orexin 2 Receptor Agonists
Alexander Heifetz, Mike J. Bodkin, Philip C. Biggin
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 20, pp. 7928-7930
Open Access | Times Cited: 19
Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
Ainoleena Turku, Alexandre Borrel, Teppo O. Leino, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8263-8275
Closed Access | Times Cited: 19
Design and synthesis of novel orexin 2 receptor agonists based on naphthalene skeleton
Tsubasa Hino, Tsuyoshi Saitoh, Yasuyuki Nagumo, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 59, pp. 128530-128530
Open Access | Times Cited: 10
Orexin research: patent news from 2016
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 10, pp. 1123-1133
Closed Access | Times Cited: 17
Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives
Pilar Marcos, Rafael Coveñas
Applied Sciences (2023) Vol. 13, Iss. 13, pp. 7596-7596
Open Access | Times Cited: 5
Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice
Yohei Sagawa, Masatoshi Sato, Noriaki Sakai, et al.
Neuropharmacology (2016) Vol. 110, pp. 268-276
Closed Access | Times Cited: 14
Discovery of orexin 2 receptor selective and dual orexin receptor agonists based on the tetralin structure: Switching of receptor selectivity by chirality on the tetralin ring
Keita Iio, Tsuyoshi Saitoh, Ryuichiro Ohshita, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 60, pp. 128555-128555
Open Access | Times Cited: 8
The distribution of hypocretin/orexin receptor mRNA in the mouse and human brain
Sanjida Mir, Ryan J. Keenan, Romke Bron, et al.
Medicine in Drug Discovery (2024) Vol. 24, pp. 100202-100202
Open Access | Times Cited: 1
Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26
Maiju K. Rinne, Teppo O. Leino, Ainoleena Turku, et al.
European Journal of Pharmacology (2018) Vol. 837, pp. 137-144
Closed Access | Times Cited: 14
Essential structure of orexin 1 receptor antagonist YNT-707, Part II: Drastic effect of the 14-hydroxy group on the orexin 1 receptor antagonistic activity
Sayaka Ohrui, Naoshi Yamamoto, Tsuyoshi Saitoh, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 28, Iss. 4, pp. 774-777
Closed Access | Times Cited: 13
Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12
Synthesis of Pyrrolo[3,4-b]pyridin-5-ones via Ugi–Zhu Reaction and In Vitro–In Silico Studies against Breast Carcinoma
Ivette Morales-Salazar, Carlos E. Garduño-Albino, Flora P. Montes-Enríquez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1562-1562
Open Access | Times Cited: 4
Characterization of a putative orexin receptor in Ciona intestinalis sheds light on the evolution of the orexin/hypocretin system in chordates
Maiju K. Rinne, Lauri Urvas, Ilona Mandrika, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Computational Analysis of Fully Activated Orexin Receptor 2 Across Various Thermodynamic Ensembles with Surface Tension Monitoring
Rafael Doležal
(2024)
Open Access | Times Cited: 1
On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding
Daniël Hoyer, Laura H. Jacobson
Medicine in Drug Discovery (2024) Vol. 22, pp. 100190-100190
Open Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Healthy Sleep, Orexin System and Addiction
Ana Clementina Equihua-Benítez, Fabio García‐García
Revista Internacional de Investigación en Adicciones (2024) Vol. 10, Iss. 1, pp. 80-90
Closed Access | Times Cited: 1
Determinants of Orexin Receptor Binding and Activation—A Molecular Dynamics Study
Lasse Karhu, Aniket Magarkar, Alex Bunker, et al.
The Journal of Physical Chemistry B (2019) Vol. 123, Iss. 12, pp. 2609-2622
Open Access | Times Cited: 11
Neurophysiology and Treatment of Disorders of Consciousness Induced by Traumatic Brain Injury: Orexin Signaling as a Potential Therapeutic Target
Huiling Tang, Qiumei Zhu, Wei Li, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 39, pp. 4208-4220
Closed Access | Times Cited: 11
Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H4 receptor antagonist against cisplatin-induced anorexia in mice
Kouichi Yamamoto, Rikuya Okui, Atsushi Yamatodani
Naunyn-Schmiedeberg s Archives of Pharmacology (2019) Vol. 392, Iss. 8, pp. 925-936
Closed Access | Times Cited: 10
Pharmacologic Management of Excessive Daytime Sleepiness
Shinichi Takenoshita, Seiji Nishino
Sleep Medicine Clinics (2020) Vol. 15, Iss. 2, pp. 177-194
Closed Access | Times Cited: 9
A comparison of mood, quality of life and executive function among narcolepsy type 1 patients with or without ADHD symptoms in China
Shan Qu, Peipei Wang, Mengmeng Wang, et al.
Sleep Medicine (2022) Vol. 97, pp. 47-54
Closed Access | Times Cited: 6
Evaluation of the efficacy of the hypocretin/orexin receptor agonists TAK‐925 and ARN‐776 in narcoleptic orexin/tTA; TetO‐DTA mice
Yu Sun, Alok Ranjan, Ryan K. Tisdale, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Open Access | Times Cited: 3
Understanding sleep-wake mechanisms and drug discovery
Ana Clementina Equihua-Benítez, Khalil Guzmán-Vásquez, René Drucker-Colı́n
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 7, pp. 643-657
Closed Access | Times Cited: 9

Scroll to top